Publication rates and characteristics of PGY2 psychiatric pharmacy resident research projects.

Autor:	Antley DL; PGY2 Psychiatric Pharmacy Resident, Center for Behavioral Medicine, Kansas City, Missouri., Nelson LA; Professor of Pharmacy Practice and Administration, University of Missouri-Kansas City School of Pharmacy, Kansas City, Missouri, nelsonla@umkc.edu., Kriz CR; Clinical Research Coordinator, University of Missouri-Kansas City School of Pharmacy, Kansas City, Missouri., Iuppa CA; Clinical Pharmacy Manager and PGY2 Residency Program Director, Center for Behavioral Medicine, Kansas City, Missouri., Lang SE; Clinical Pharmacist, Center for Behavioral Medicine, Kansas City, Missouri., Gramlich NA; Clinical Pharmacy Manager, Northwest Missouri Psychiatric Rehabilitation Center, St Joseph, Missouri., Elliott ESR; Director of Pharmacy, Center for Behavioral Medicine, Kansas City, Missouri; and Northwest Missouri Psychiatric Rehabilitation Center, St Joseph, Missouri., Sommi RW; Associate Dean & Professor of Pharmacy Practice and Psychiatry, University of Missouri-Kansas City School of Pharmacy, Kansas City, Missouri.
Jazyk:	angličtina
Zdroj:	The mental health clinician [Ment Health Clin] 2023 Jan 05; Vol. 12 (6), pp. 350-355. Date of Electronic Publication: 2023 Jan 05 (Print Publication: 2022).
DOI:	10.9740/mhc.2022.12.350
Abstrakt:	Introduction: To describe the publication rates and characteristics of PGY2 psychiatric pharmacy residency projects presented as a poster presentation at the annual meetings of the College of Psychiatric and Neurologic Pharmacists (CPNP) from 2002 to 2018. (As of 2022 the organization is under the name, American Association of Psychiatric Pharmacists.). Methods: CPNP abstracts from even years were strategically searched in PubMed, Ovid MEDLINE, and Google Scholar. If a publication was identified, additional data were collected for characterization, including study information, journal information, author information, institutional affiliation, publication year, and time to publication. Results: A total of 348 abstracts were evaluated. Publication in a journal was achieved for 60 projects (17.2%), with publication rates decreasing from 2012 to 2018. The mean time to publication was 17.3 months after completion of the residency, with most projects published at 8 months. More than half (51.7%) of these projects were published in a psychiatric pharmacy journal affiliated with CPNP. Study designs were predominantly retrospective, observational, cohort studies with a focus on evaluation of a drug therapy outcome. The PGY2 resident was the first author in 90% of the publications. Forty percent included other health care professionals outside of pharmacy as a coauthor. PGY2 residencies affiliated with academic institutions had overall higher publications rates. Discussion: Publication rates for PGY2 psychiatric pharmacy residency projects are low and are decreasing over time despite an increasing number of PGY2 psychiatric pharmacy residency programs. This publication rate is lower than that reported in the literature for PGY2 critical care residency programs. The downward trend of publication rates for PGY2 psychiatric pharmacy residency projects is concerning. (© 2022 AAPP. The Mental Health Clinician is a publication of the American Association of Psychiatric Pharmacists.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu